150 related articles for article (PubMed ID: 31999451)
1. Bifunctional Naphthoquinone Aromatic Amide-Oxime Derivatives Exert Combined Immunotherapeutic and Antitumor Effects through Simultaneous Targeting of Indoleamine-2,3-dioxygenase and Signal Transducer and Activator of Transcription 3.
Huang R; Jing X; Huang X; Pan Y; Fang Y; Liang G; Liao Z; Wang H; Chen Z; Zhang Y
J Med Chem; 2020 Feb; 63(4):1544-1563. PubMed ID: 31999451
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Biological Evaluation of Novel 2-Amino-1,4-Naphthoquinone Amide-Oxime Derivatives as Potent IDO1/STAT3 Dual Inhibitors with Prospective Antitumor Effects.
Huang RZ; Liang QL; Jing XT; Wang K; Zhang HY; Wang HS; Ma XL; Wei JH; Zhang Y
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630387
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel sulfonamide chromone-oxime derivatives as potent indoleamine 2,3-dioxygenase 1 inhibitors.
Wang K; Song LH; Liang QL; Zhang Y; Ma XL; Wang Q; Zhang HY; Jiang CN; Wei JH; Huang RZ
Eur J Med Chem; 2023 Jun; 254():115349. PubMed ID: 37060754
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of 1,2,5-oxadiazole-3-carboximidamide derivatives as novel indoleamine-2,3-dioxygenase 1 inhibitors.
Song X; Sun P; Wang J; Guo W; Wang Y; Meng LH; Liu H
Eur J Med Chem; 2020 Mar; 189():112059. PubMed ID: 31981851
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Biological Evaluation of Novel 1,2,5-Oxadiazol-3- Carboximidamide Derivatives as Indoleamine 2, 3-Dioxygenase 1 (IDO1) Inhibitors.
Xia Z; Nan Y; Liu C; Lin G; Gu K; Chen C; Zhao W; Ju D; Dong X
Anticancer Agents Med Chem; 2020; 20(13):1592-1603. PubMed ID: 32496990
[TBL] [Abstract][Full Text] [Related]
6. Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents.
Wen H; Liu Y; Wang S; Wang T; Zhang G; Chen X; Li Y; Cui H; Lai F; Sheng L
Molecules; 2019 Jun; 24(11):. PubMed ID: 31195673
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel naphthoquinone derivatives as IDO1 inhibitors.
Pan L; Zheng Q; Chen Y; Yang R; Yang Y; Li Z; Meng X
Eur J Med Chem; 2018 Sep; 157():423-436. PubMed ID: 30103191
[TBL] [Abstract][Full Text] [Related]
8. Discovery of IDO1 and DNA dual targeting antitumor agents.
Fang K; Wu S; Dong G; Wu Y; Chen S; Liu J; Wang W; Sheng C
Org Biomol Chem; 2017 Dec; 15(47):9992-9995. PubMed ID: 29177308
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as IDO1/TDO dual inhibitors.
Cui G; Lai F; Wang X; Chen X; Xu B
Eur J Med Chem; 2020 Feb; 188():111985. PubMed ID: 31881488
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and structure-activity relationship study of novel naphthoindolizine and indolizinoquinoline-5,12-dione derivatives as IDO1 inhibitors.
Yang R; Chen Y; Pan L; Yang Y; Zheng Q; Hu Y; Wang Y; Zhang L; Sun Y; Li Z; Meng X
Bioorg Med Chem; 2018 Sep; 26(17):4886-4897. PubMed ID: 30170925
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and antitumor study of a series of N-Cyclic sulfamoylaminoethyl substituted 1,2,5-oxadiazol-3-amines as new indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors.
Chen S; Guo W; Liu X; Sun P; Wang Y; Ding C; Meng L; Zhang A
Eur J Med Chem; 2019 Oct; 179():38-55. PubMed ID: 31233921
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 5-(N-hydroxycarbamimidoyl) benzofuran derivatives as novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Jung J; Yoon H; Sohn TI; Jang K; Yoo Y; Jeong I; Shin JE; Lee JH; Ann J; Lee J
Bioorg Med Chem Lett; 2021 May; 40():127963. PubMed ID: 33741464
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of Synthesized 1,4-Naphthoquinone Oxime Derivatives on Selected Human Cancer Cell Lines.
Zhang Q; Dong J; Cui J; Huang G; Meng Q; Li S
Chem Pharm Bull (Tokyo); 2018; 66(6):612-619. PubMed ID: 29863062
[TBL] [Abstract][Full Text] [Related]
14. Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
Kumar S; Malachowski WP; DuHadaway JB; LaLonde JM; Carroll PJ; Jaller D; Metz R; Prendergast GC; Muller AJ
J Med Chem; 2008 Mar; 51(6):1706-18. PubMed ID: 18318466
[TBL] [Abstract][Full Text] [Related]
15. 4,5-Disubstituted 1,2,3-triazoles: Effective Inhibition of Indoleamine 2,3-Dioxygenase 1 Enzyme Regulates T cell Activity and Mitigates Tumor Growth.
Panda S; Pradhan N; Chatterjee S; Morla S; Saha A; Roy A; Kumar S; Bhattacharyya A; Manna D
Sci Rep; 2019 Dec; 9(1):18455. PubMed ID: 31804586
[TBL] [Abstract][Full Text] [Related]
16. The first indoleamine-2,3-dioxygenase-1 (IDO1) inhibitors containing carborane.
Austin CJ; Kahlert J; Issa F; Reed JH; Smith JR; Ioppolo JA; Ong JA; Jamie JF; Hibbs D; Rendina LM
Dalton Trans; 2014 Jul; 43(28):10719-24. PubMed ID: 24752804
[TBL] [Abstract][Full Text] [Related]
17. Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO).
Pan S; Zhou Y; Wang Q; Wang Y; Tian C; Wang T; Huang L; Nan J; Li L; Yang S
Eur J Med Chem; 2020 Dec; 207():112703. PubMed ID: 32871341
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of a novel indoleamine 2,3-dioxigenase 1 (IDO1) and thioredoxin reductase (TrxR) dual inhibitor.
Fan QZ; Zhou J; Zhu YB; He LJ; Miao DD; Zhang SP; Liu XP; Zhang C
Bioorg Chem; 2020 Dec; 105():104401. PubMed ID: 33113415
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel hydroxyamidine derivatives as indoleamine 2,3-dioxygenase 1 inhibitors with in vivo anti-tumor efficacy.
Liu C; Nan Y; Xia Z; Gu K; Chen C; Dong X; Ju D; Zhao W
Bioorg Med Chem Lett; 2020 Apr; 30(8):127038. PubMed ID: 32088128
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of flavonoids isolated from
Kwon M; Ko SK; Jang M; Kim GH; Ryoo IJ; Son S; Ryu HW; Oh SR; Lee WK; Kim BY; Jang JH; Ahn JS
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1481-1488. PubMed ID: 31423846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
